Literature DB >> 23173652

Plasma-mediated immune suppression: a neonatal perspective.

Mirjam E Belderbos1, Ofer Levy, Linde Meyaard, Louis Bont.   

Abstract

Plasma is a rich mixture of immune regulatory factors that shape immune cell function. This immunomodulatory role of plasma is especially important in neonates. To maintain in utero feto-maternal tolerance and to allow for microbial colonization after birth, the neonatal immune system is biased against pro-inflammatory responses while favoring immune suppression. Therefore, the neonatal period provides a unique opportunity to study the physiologic mechanisms regulating the immune system. Several recent studies in neonates have identified plasma factors that play a key role in immune regulation. Insight into immune regulation by neonatal and adult plasma may have clinical implications, because plasma is easily accessible, affordable, and widely available. Herein, we review plasma-mediated immune regulation, with specific focus on neonatal plasma. We discuss how immune suppression is a key function of plasma and provide a systematic overview of the published literature regarding plasma-derived immune suppressive proteins, lipids, purines, and sugars. Finally, we outline how immune regulation by these factors, which are particularly abundant in neonatal plasma, may eventually be used to treat immune-mediated diseases, such as autoimmune, allergic, and inflammatory diseases.
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23173652     DOI: 10.1111/pai.12023

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  29 in total

Review 1.  Neonatal Vaccination: Challenges and Intervention Strategies.

Authors:  Matthew C Morris; Naveen Surendran
Journal:  Neonatology       Date:  2016-01-13       Impact factor: 4.035

Review 2.  A prime time for trained immunity: innate immune memory in newborns and infants.

Authors:  Ofer Levy; James L Wynn
Journal:  Neonatology       Date:  2013-12-18       Impact factor: 4.035

Review 3.  Impact of pregravid obesity on maternal and fetal immunity: Fertile grounds for reprogramming.

Authors:  Suhas Sureshchandra; Nicole E Marshall; Ilhem Messaoudi
Journal:  J Leukoc Biol       Date:  2019-09-04       Impact factor: 4.962

Review 4.  Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection.

Authors:  Michelle L Korir; Shannon D Manning; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

5.  Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates.

Authors:  Whitney A Young; Eleanor A Fallon; Daithi S Heffernan; Philip A Efron; William G Cioffi; Alfred Ayala
Journal:  Surgery       Date:  2016-12-21       Impact factor: 3.982

6.  High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates.

Authors:  Thierry Roger; Anina Schneider; Manuela Weier; Fred C G J Sweep; Didier Le Roy; Jürgen Bernhagen; Thierry Calandra; Eric Giannoni
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

7.  α-Galactosylceramide stimulates splenic lymphocyte proliferation in vitro and increases antibody production in vivo in late neonatal-age mice.

Authors:  Q Chen; A C Ross
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

Review 8.  Immune responses in neonates.

Authors:  Saleem Basha; Naveen Surendran; Michael Pichichero
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

Review 9.  Ontogeny of early life immunity.

Authors:  David J Dowling; Ofer Levy
Journal:  Trends Immunol       Date:  2014-05-28       Impact factor: 16.687

Review 10.  Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms.

Authors:  K L Flanagan; R van Crevel; N Curtis; F Shann; O Levy
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.